Mineralys Therapeutics (MLYS) IPO deck
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.
![](/content/images/size/w1304/2023/02/MLYS_01-1.png)
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.